Literature DB >> 34508643

Beating a benchmark: Boron neutron capture therapy for recurrent and refractory meningiomas.

Martin C Tom1,2, Rupesh Kotecha1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34508643      PMCID： PMC8730769          DOI： 10.1093/neuonc/noab217

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  9 in total

Review 1.  Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

Authors:  Thomas Kaley; Igor Barani; Marc Chamberlain; Michael McDermott; Katherine Panageas; Jeffrey Raizer; Leland Rogers; David Schiff; Michael Vogelbaum; Damien Weber; Patrick Wen
Journal:  Neuro Oncol       Date:  2014-02-04       Impact factor: 12.300

2.  High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.

Authors:  C Leland Rogers; Minhee Won; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; Shannon E Fogh; Emad Youssef; Nimisha Deb; Young Kwok; Clifford G Robinson; Hui-Kuo Shu; Barbara J Fisher; Valerie Panet-Raymond; William G McMillan; John F de Groot; Peixin Zhang; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-11-29       Impact factor: 7.038

3.  Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam Reirradiation.

Authors:  Brandon S Imber; Brian Neal; Dana L Casey; Heba Darwish; Andrew L Lin; Oren Cahlon; Brian Chon; Henry Tsai; Eugen Hug; Yoshiya Yamada; T Jonathan Yang
Journal:  Int J Part Ther       Date:  2019-05-01

4.  Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.

Authors:  Wenya Linda Bi; Lakshmi Nayak; David M Meredith; Joseph Driver; Ziming Du; Samantha Hoffman; Yvonne Li; Eudocia Quant Lee; Rameen Beroukhim; Mikael Rinne; Ricardo McFaline-Figueroa; Ugonma Chukwueke; Christine McCluskey; Sarah Gaffey; Andrew D Cherniack; Jennifer Stefanik; Lisa Doherty; Christina Taubert; Meghan Cifrino; Deborah LaFrankie; Thomas Graillon; Patrick Y Wen; Keith L Ligon; Ossama Al-Mefty; Raymond Y Huang; Alona Muzikansky; E Antonio Chiocca; Sandro Santagata; Ian F Dunn; David A Reardon
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 12.300

5.  Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.

Authors:  Rupesh Kotecha; Raees Tonse; Haley Appel; Yazmin Odia; Ritesh R Kotecha; Guilherme Rabinowits; Minesh P Mehta
Journal:  Curr Oncol       Date:  2021-04-18       Impact factor: 3.677

6.  Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.

Authors:  Rami A El Shafie; Maja Czech; Kerstin A Kessel; Daniel Habermehl; Dorothea Weber; Stefan Rieken; Nina Bougatf; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2018-05-08       Impact factor: 3.481

7.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Authors:  Quinn T Ostrom; Nirav Patil; Gino Cioffi; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-10-30       Impact factor: 12.300

8.  Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up.

Authors:  Satoshi Takai; Masahiko Wanibuchi; Shinji Kawabata; Koji Takeuchi; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-Ichi Miyatake
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 12.300
  9 in total
  1 in total

Review 1.  Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives.

Authors:  Hajime Takase; Tetsuya Yamamoto
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.